State of Art of Cancer Pharmacogenomics in Latin American Populations
AbstractOver the past decades, several studies have shown that tumor-related somatic and germline alterations predicts tumor prognosis, drug response and toxicity. Latin American populations present a vast geno-phenotypic diversity due to the great interethnic and interracial mixing. This genetic flow leads to the appearance of complex characteristics that allow individuals to adapt to endemic environments, such as high altitude or extreme tropical weather. These genetic changes, most of them subtle and unexplored, could establish a mutational profile to develop new pharmacogenomic therapies specific for Latin American populations. In this review, we present the current status of research on somatic and germline alterations in Latin America compared to those found in Caucasian and Asian populations. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
López-Cortés, A.; Guerrero, S.; Redal, M.A.; Alvarado, A.T.; Quiñones, L.A. State of Art of Cancer Pharmacogenomics in Latin American Populations. Int. J. Mol. Sci. 2017, 18, 639.
López-Cortés A, Guerrero S, Redal MA, Alvarado AT, Quiñones LA. State of Art of Cancer Pharmacogenomics in Latin American Populations. International Journal of Molecular Sciences. 2017; 18(6):639.Chicago/Turabian Style
López-Cortés, Andrés; Guerrero, Santiago; Redal, María A.; Alvarado, Angel T.; Quiñones, Luis A. 2017. "State of Art of Cancer Pharmacogenomics in Latin American Populations." Int. J. Mol. Sci. 18, no. 6: 639.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.